Atlas Trials

Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer

Clinical trial NCT02028494 · UNKNOWN

Trial details

NCT number
NCT02028494
Sponsor
Latin American & Caribbean Society of Medical Oncology
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2013-08-01
Primary completion
2018-12-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.